Research Compound Summary Compound: Retatrutide CAS Number: 2381089-83-2 Molecular Formula: C205H320N56O63S2 Purity: 99.71% (HPLC-UV verified) Third-Party Testing: Testides Analytical (independent lab, Toronto) COA Download: View Full COA (PDF) Report: DBAV-RETA-10-062726 Source: Canadian manufactured Shipping: Same-day from our BC facility Retatrutide peptide Canada: a novel triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
The price charged for a product or service will be the price in effect at the time the order is placed and will be set out in Users order confirmation email
These cancers arise from different cell types and follow distinct biological pathways
The decision to scrap the plan by the budget-slashing Trump administration could make things much harder for millions of people with obesity, however
Conversely, if you're unable to take your GLP-1 medication due to illness, blood glucose levels may rise
If youre interested in a structured low-dose approach, Nooms Microdose GLP-1 Rx Program is designed specifically for thatwith medication included, a dedicated titration protocol, and built-in support tools
